C‐reactive protein as a predictor of improvement and readmission in heart failure
Open Access
- 10 October 2002
- journal article
- clinical trial
- Published by Wiley
- Vol. 4 (3) , 331-336
- https://doi.org/10.1016/s1388-9842(02)00021-1
Abstract
Objectives: Only recently, new risk factors to explain atherosclerotic disease have been identified. One of the most important clinical manifestations of atherosclerosis is heart failure. Our study ...Keywords
This publication has 24 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Nontraditional Cardiovascular Risk FactorsThe Lancet Healthy Longevity, 1999
- How to diagnose diastolic heart failureEuropean Heart Journal, 1998
- The activated immune system in congestive heart failure – from dropsy to the cytokine paradigmJournal of Internal Medicine, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Epidemiology of congestive heart failureThe American Journal of Cardiology, 1985
- Isolation of Human C-Reactive Protein Complementary DNA and Localization of the Gene to Chromosome 1Science, 1983
- STUDIES OF ACUTE PHASE PROTEINThe Journal of Experimental Medicine, 1961